DILEvetam-I
Description_Effects
DILEvetam-I is an antiepileptic medication specifically formulated for the treatment of partial-onset seizures, with or without secondary generalisation, in adults. It contains Levetiracetam, a widely used anticonvulsant known for its effectiveness, rapid onset of action, and minimal drug interactions. Partial-onset seizures occur when abnormal electrical activity starts in one part of the brain and may or may not spread to other areas. DILEvetam-I helps stabilize this abnormal activity, thereby reducing the frequency and severity of seizures. Levetiracetam, the active ingredient in DILEvetam-I, works by binding to a specific protein in the brain known as SV2A, which is involved in the release of neurotransmitters. This helps prevent the uncontrolled firing of neurons, which causes seizures. It is typically used as adjunctive therapy, meaning it is added to an existing seizure treatment regimen when additional control is needed. DILEvetam-I is usually taken twice a day, with or without food. It is well-tolerated by most patients, and common side effects may include drowsiness, dizziness, mood changes, or fatigue. As with any antiepileptic drug, it’s important not to discontinue use abruptly without consulting your doctor, as this can increase seizure risk. Always follow medical guidance for dosage and monitoring.
